EUVIMEDEUVIMED entdecken
Editorial

Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?

Kathleen M Giacomini iD, Piet H van der Graaf

Clinical Pharmacology & Therapeutics · 2024-10 · 116 (4) · 885-889

DOI: 10.1002/cpt.3404 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 17.09.2024. Verfasst von Kathleen M Giacomini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Pharmacogenomic Testing, Pharmacogenetics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical pharmacology is a discipline that includes education, research, and the implementation of knowledge into clinical practice, which ranges from precision dosing to therapeutic drug monitoring, and most recently, to the implementation of pharmacogenetic/pharmacogenomic (PGx) testing services to precisely administer drugs based on an individual's genetic make-up.In fact, PGx has become one of the core scientific pillars of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) and its flagship journal, Clinical Pharmacology & Therapeutics (CPT).PGx implementation services have been rapidly adopted in academic healthcare centers throughout the United States and in Europe.These services are grounded in the availability of new genetic technologies and a wealth of scientific discoveries, generally describing the influence of genetic variants on drug responses in European ancestral populations.With the availability of PGx information, the Clinical Pharmacogenetics Implementation Consortium (CPIC) was established to develop guidelines on drug and dose selection for individuals based on their genetic information.1 These guidelines, published in CPT, 2,3 are increasingly being incorporated into clinical decision support systems, and used to advise providers on how to use PGx information in drug or dose selection.1 However, despite of their widespread adoption in academic medical centers, there remains a resistance to PGx testing among healthcare providers.This can be attributed to various factors, such as cost of testing, requirements for expensive infrastructure, lack of provider education, and skepticism that there is any major benefit of testing.4 With the goal of stimulating discussion among clinical pharmacologists and others, the editors of CPT sponsored a session at the 2024 annual meeting of ASCPT, entitled: "Is pharmacogenetic testing a vital tool for enhancing therapeutic management of patients worldwide?"(Colorado Springs CO, March 28, 2024).The session, which was moderated by CPT Editor-in-Chief, Piet van der Graaf, and Deputy Editor, Kathleen Giacomini, included four clinical pharmacologists or geneticists who brought different types of expertise to the panel

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharmacogenomic TestingPharmacogeneticsHumansPrecision Medicine

Autor:innen und Institutionen

  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA.
  • Certara, Applied BioSimulation, Canterbury, UK.
  • Leiden Academic Centre for Drug Research, Leiden, The Netherlands.

ORCID-Profile: Kathleen M Giacomini

Zitieren

APA

Giacomini, K. M., & van der Graaf, P. H. (2024). Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?. Clinical Pharmacology & Therapeutics, 116(4), 885-889. https://doi.org/10.1002/cpt.3404

Vancouver

Giacomini KM, van der Graaf PH. Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?. Clinical Pharmacology & Therapeutics. 2024;116(4):885-889. doi:10.1002/cpt.3404

BibTeX
@article{Giacomini2024,
  author = {Giacomini, Kathleen M and van der Graaf, Piet H},
  title = {Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  volume = {116},
  number = {4},
  pages = {885--889},
  doi = {10.1002/cpt.3404}
}
Kostenlos starten →